It is intended for people who have already reached and tolerated the 2.4mg dose
PMC 3130335
Competing interests JC: provided consultation to Acadia, Actinogen, Acumen, Alpha Cognition, Aprinoia, AriBio, Artery, Biogen, BioVie, Cassava, Cerecin, Diadem, EIP Pharma, Eisai, GemVax, Genentech, GAP Innovations, Janssen, Jocasta, Karuna, Lilly, Lundbeck, LSP, Merck, NervGen, Novo Nordisk, Oligomerix, Optoceutics, Ono, Otsuka, PRODEO, Prothena, reMYND, Roche, Sage Therapeutics, Signant Health, Simcere, Suven, SynapseBio, TrueBinding, Vaxxinity, and Wren Therapeutics
Homer AR, Taylor FC, Dempsey PC et al (2021) Frequency of interruptions to sitting time: benefits for postprandial metabolism in type 2 diabetes
Patients and colleagues in other specialties are going to seek the input of retina specialists regarding the use of GLP-1 RAs
Frequently Asked Questions Is hearing loss a recognised side effect of Ozempic